CASODEX Pages on BioPortfolio:

Biotechnology News CASODEX Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/CASODEX-news.htm...

BioPortfolio - Casodex
Casodex - BioPortfolio - Indepth. ... Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R), 7th July, 2009, Mylan Inc. ...
http://www.bioportfolio.com/indepth/Casodex.html...

Biotechnology News BICALUTAMIDE Search
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets Source: Caraco Pharmaceutical Laboratories, Ltd. Buzz up! ...
http://www.bioportfolio.co.uk/BICALUTAMIDE-news.htm...

BioPortfolio Limited Stakeholder Insight Prostate Cancer ...
Casodex is by far the preferred anti-androgen for use as monotherapy in each of ... Casodex 150mg is still used in localized prostate cancer, according to ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1037.html...

BioPortfolio Limited Prostate Cancer - Hormone-refractory patients ...
Casodex is by far the preferred anti-androgen for use as monotherapy in each of the seven ... Casodex 150mg has had a tumultuous regulatory pathway to date ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_310.html...

BioPortfolio.com - BioWeb Mastocytosis Search
... EQ 180MG BASE/5ML SUSPENSION) (CEPHALOSPORIN) 20-498 CASODEX ZENECA BICALUTAMIDE 14-SEP-95 (TABLET) WILMINGTON, DE 50MG 19850 (ANTIANDROGEN) [USE IN
. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Mylan Inc. - Mylan Receives FDA Approval for ...
Approval for Generic Version of Prostate Cancer Treatment Casodex(R) Begins ... Treatment Casodex(R) · Mylan Schedules Second Quarter 2009 Financial Results ...
http://www.bioportfolio.com/news/Mylan-Receives-FDA-Approval...

BioPortfolio.com - BioWeb CEDAX CEFTIBUTEN DIHYDRATE Search
... NJ EQ 90MG BASE/5ML FOR ORAL 07033 EQ 180MG BASE/5ML SUSPENSION) ( CEPHALOSPORIN) 20-498 CASODEX ZENECA BICALUTAMIDE 14-SEP-95 (TABLET) WILMINGTON,
. ...
http://www.bioportfolio.co.uk/CEDAX+CEFTIBUTEN+DIHYDRATE-bio...

Datamonitor Pharmaceutical and Biotechnology Reports
As a result of market dominance by agents such as leuprolide, and AstraZeneca's Zoladex (goserelin) and Casodex (bicalutamide), there is little space in the ...
http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor.htm...

Results from other life science and pharmaceutical sites:

Casodex, cosudex, (bicalutamide) - anti androgen, prostate cancer ...
Casodex, Cosudex (bicalutamide) information, an anti androgen for prostate cancer provided by AstraZeneca.
http://www.astrazeneca.com/medicines/?itemId=3888008...

Bicalutamide - Wikipedia, the free encyclopedia
Bicalutamide (marketed as Casodex, Cosudex, Calutide, Kalumid) is an oral non- steroidal anti-androgen used in the treatment of prostate cancer and hirsutism
...
http://en.wikipedia.org/wiki/Bicalutamide...

Casodex (Bicalutamide) tablet - DailyMed: About DailyMed
CASODEX® (bicalutamide) Tablets for oral administration contain 50 mg of bicalutamide, a non-steroidal antiandrogen with no other known endocrine
activity. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4740...

The pharmacokinetics of Casodex enantiomers in subjects with ...
Casodex is a novel non-steroidal antiandrogen being developed for the treatment of prostatic cancer. The antiandrogenic activity is predominantly in the ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364687/...

Casodex (bicalutamide) Tablets February 2009
11 Jul 2009 ... Casodex (bicalutamide) Tablets February 2009. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...

Health and Drug Alerts: Safety updates: repaglinide (GlucoNorm ...
(Health Canada has not approved Casodex 150 mg for the treatment of locally advanced disease ... Important drug safety information: Casodex 150 mg [letter].
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC203288/...

ASTRAZENECA LAUNCHES CASODEX 150mg - AstraZeneca International ...
'Casodex' 150 mg, a single daily tablet for the treatment of prostate cancer, is now available in the UK, the first market world-wide in which this new ...
http://www.astrazeneca.com/media/latest-press-releases/1999/...

Casodex treatment induces hypoxia-related gene expression in the ...
We examined the gene expression profile in the LNCaP prostate cancer progression model during chronic treatment with Casodex using cDNA microarrays ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079894/...

Prostate Cancer and Prostatic Diseases - Abstract of article ...
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind
...
http://www.nature.com/pcan/journal/v8/n2/abs/4500799a.html...

ASTRAZENECA SUBMITS SUPPLEMENTAL NEW DRUG APPLICATION TO FDA ...
“If this new indication for Casodex is approved, it could be another option for ... Casodex is a trademark, property of the AstraZeneca group of companies. ...
http://www.astrazeneca.com/media/latest-press-releases/2001/...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.